Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Which Matters More Index Level Or Market Price weighs the importance of index readings versus market price for informed decisions.
28,620 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Christie’s New York Spring Auction Week posted $1.45 billion in sales, led by a Pollock that fetched $181 million. Th...
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
As 2026 unfolds, three robotics stocks stand out in the M&A spotlight, driven by cash flow, autonomous tech stacks, a...
Citi lowers Lucid's price target to $14 following a disappointing Q1 2026 and the withdrawal of 2026 guidance, while ...
As housing layouts and budgets shift, consumers are rethinking bed sizes. This guide outlines how to measure space an...
Warner Bros. Discovery’s latest quarterly results underscore a tougher operating environment even as deal drama swirl...
CoStar Group appoints Robin Rossmann as chief financial officer, effective July 31, 2026, succeeding Christian Lown. ...
CertifID unveils a broader, end-to-end closing platform, adding AI payoff ordering, document workflows, and digital p...
A federal judge paused the $81 billion Paramount-Warner merger for two weeks as 12 states challenge the deal over com...
A wave of commercial real estate loans is set to mature in 2026, testing lenders’ balance sheets and drawing Bitcoin ...
Micron Technology races higher on AI memory demand and supply tightness. This piece outlines why investors may consid...